Rimegepant for migraine: acute efficacy beyond the USA
Lancet Neurol
.
2023 Jun;22(6):456-457.
doi: 10.1016/S1474-4422(23)00160-6.
Author
Dimos D Mitsikostas
1
Affiliation
1
National and Kapodistrian Univeristy of Athens, Aeginition Hospital, 11521 Athens, Greece. Electronic address: dmitsikostas@uoa.gr.
PMID:
37210086
DOI:
10.1016/S1474-4422(23)00160-6
No abstract available
Publication types
Comment
MeSH terms
Humans
Migraine Disorders* / drug therapy
Piperidines* / therapeutic use
Pyridines
Substances
rimegepant sulfate
Piperidines
Pyridines